JPRN-UMIN000015933已完成未知
Inhibition Effects of Hepatocellular Carcinoma Developments for Interferon-Free, Direct-Acting Antiviral Agents for Hepatitis C Virus - DAAs for HCV and Hepatocellular Carcinoma Developments
The Research Center for Hepatitis and Immunology National Center for Global Health and Medicine (NCGM)0 个研究点目标入组 609 人开始时间: 2014年12月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 609
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •non SVR IFN without Protease inhibitor
研究者
相似试验
已完成
不适用
Prevention of hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis by pegylated IFN-alpha-2a after surgical resection or radiofrequency ablatiochronic hepatitis C,cirrhosis,hepatocellular carcinomaJPRN-C000000203Gunma Liver Study Group100
招募中
不适用
Sequential therapy for hepatocellular carcinoma -Real world evidence of TKI in prospective observational studyhepatocellular carcinomaJPRN-UMIN000038867Kyushu Study group of Clinical Cancer500
进行中（未招募）
1 期
Hepatocellular carcinoma less than 3 cm treated with percutaneous tumour destruction: multicentric phase 2 trial assessing the impact of idarubicin-lipiodol intra-arterial chemotherapy on hepatic recurrence.The research hypothesis is that hepatic locoregional treatment with idarubicin and lipiodol would be an effective adjuvant therapy of hepatocellular carcinomaEUCTR2019-001362-15-FRniversity Hospital of Montpellier138
已完成
2 期
Specific anti hepatocellular carcinoma dendritic cells implantation as therapy or adjuvant treatment for patients with advanced hepatocellular carcinoma.C22Malignant neoplasm of liver and intrahepatic bile ductsDRKS00016606Faculty of medicine-Tanta University20
招募中
不适用
Risk of Hepatocellular Carcinoma or Decompensated Liver Cirrhosis in Patients with Chronic Liver Injury via Shear wave with Smart maps (HCC DLC-SwSm Trial)Patients with chronic liver injury or liver cirrhosisJPRN-UMIN000017323Hiroshima City Hospital1,000